Professional \ Focused \ Dedicated
Dark circles and redness under the eyes are the most common skin problems that can be improved but are difficult to cure. Readers who suffer from this problem know it very well!
There is an ingredient - Troxerutin, which is commonly used in foreign countries in the treatment of phlebitis, hemorrhoids, improvement of dark circles under the eyes, redness, anti-aging and other products.
Pharmacologically, the significant effects of triclopyr: can reduce abnormal capillary blood seepage, improve vascular damage, protection of endothelial cells, promote new angiogenesis, contraction of capillaries, improve venous diastole and so on.
Product Name: Troxerutin
Chemical formula:C33H42O19
Molecular weight:742.675
CAS No.:7085-55-4
Appearance: Yellow and yellow-green powder
Applications: Troxerutin is classified as a bioflavonoid. It is a hydroxy ethylated derivative of rutin, which is used directly as an API and has a variety of pharmacological effects:
Inhibition of platelet and red blood cell coagulation: Troxerutin can inhibit the coagulation of platelets and red blood cells, thus preventing the formation of blood clots.
Improvement of microcirculation: Troxerutin can increase the oxygen content in the blood, improve microcirculation, and promote neo angiogenesis to enhance collateral circulation.
Protecting endothelial cells: Troxerutin has a protective effect on endothelial cells, and can counteract vascular damage caused by 5-hydroxytryptamine and bradykinin.
Increase capillary resistance: Troxerutin can reduce capillary permeability, increase capillary resistance and prevent edema caused by elevated vascular permeability.
In addition, Troxerutin has anti-radiation damage, anti-inflammation, anti-allergy, anti-ulcer and other effects.
Benepure Pharmaceutical Co., Ltd.
Address: 99# Jirui 3rd Road, High-Tech District, Chengdu, Sichuan , China | |
Mail: info@benepure.com | |
Tel: +86 28 8679 9990 +86 28 8679 8880 | |
Fax: +86 28 8679 9924 |
Linkedln | |
Skype | |
TencentQQ | |
SinaWeibo | |